EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Inclisiran: Efficacy in Real World—Systematic Review and Meta-Analysis

Álvaro Rodrigo Alaíz iD, Luis Corral Gudino, Leopoldo Pérez de la Isla, Héctor García Pardo, David González Calle iD, José Pablo Miramontes-González iD

Journal of Clinical Medicine · 12.06.2025 · 14 (12) · 4163

DOI: 10.3390/jcm14124163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.06.2025. Verfasst von Álvaro Rodrigo Alaíz und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Valladolid University, 47003 Valladolid, Spain. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inclisiran is a novel lipid-lowering agent targeting PCSK9 via small interfering RNA (siRNA) technology. While clinical trials such as the ORION studies have demonstrated significant reductions in low-density lipoprotein cholesterol (c-LDL), real-world data (RWD) often differ due to variations in patient populations and clinical practices.

Methods

This systematic review and meta-analysis adhered to PRISMA guidelines. A comprehensive search was conducted in MEDLINE for real-world studies evaluating inclisiran’s efficacy in reducing c-LDL. Articles meeting predefined inclusion criteria were assessed for quality and bias using RTI Item Bank. Data transformations were applied to harmonize median and IQR values to means and standard deviations for meta-analytic synthesis using RevMan 5.4.

Results

A total of 3774 articles were identified, of which 7 studies comprising 1454 patients met the inclusion criteria. The meta-analysis revealed an average c-LDL reduction of 42.77% (95% CI: 37.42–48.12%). The subgroup analysis indicated greater reductions in patients receiving inclisiran alongside statins (45.67%; 95% CI: 36.64–54.71%) compared to monotherapy (37.53%; 95% CI: 29.91–45.15%). Discrepancies with clinical trials (e.g., 52% reduction in ORION studies) were attributed to baseline c-LDL differences and real-world adherence.

Conclusions

Inclisiran demonstrates robust efficacy in real-world settings, achieving significant c-LDL reductions with a convenient dosing schedule. However, the observed discrepancies with clinical trials highlight the need for further RWD studies to bridge gaps in effectiveness and optimize therapeutic outcomes.

Schlagwörter

Stichwörter der Autor:innen

PCSK9c-LDLinclisiranlipid-lowering therapymeta-analysisreal-world evidence

Autor:innen und Institutionen

  • School of Medicine, Valladolid University, 47003 Valladolid, Spain.
  • Internal Medicine Unit, Río Hortega University Hospital, 47003 Valladolid, Spain.
  • Cardiology Unit, San Carlos University, 28040 Madrid, Spain.
  • Cardiology Unit, Río Hortega University Hospital, 47012 Valladolid, Spain.
  • Cardiology Unit, Salamanca University Hospital, 37007 Salamanca, Spain.

ORCID-Profile: Álvaro Rodrigo Alaíz, David González Calle, José Pablo Miramontes-González

Zitieren

APA

Alaíz, Á. R., Gudino, L. C., de la Isla, L. P., Pardo, H. G., Calle, D. G., & Miramontes-González, J. P. (2025). Inclisiran: Efficacy in Real World—Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 14(12), 4163. https://doi.org/10.3390/jcm14124163

Vancouver

Alaíz ÁR, Gudino LC, de la Isla LP, Pardo HG, Calle DG, Miramontes-González JP. Inclisiran: Efficacy in Real World—Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025;14(12):4163. doi:10.3390/jcm14124163

BibTeX
@article{Alaz2025,
  author = {Alaíz, Álvaro Rodrigo and Gudino, Luis Corral and de la Isla, Leopoldo Pérez and Pardo, Héctor García and Calle, David González and Miramontes-González, José Pablo},
  title = {Inclisiran: Efficacy in Real World—Systematic Review and Meta-Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {4163},
  doi = {10.3390/jcm14124163}
}
Kostenlos starten →